0001437749-26-011121
SEC filingAzenta's sale of B Medical Systems to Thelema failed to close by March 31, 2026 due to Thelema's failure to secure required financing, with no assurance of future completion.
The previously announced sale of the entire issued share capital of B Medical Systems S.À R.L., a business unit under Azenta Germany GmbH, by Azenta, Inc. to Thelema S.À R.L. missed its expected closing date of March 31, 2026. The sole reason disclosed is Thelema's inability to secure final residual financing, a customary closing condition. Despite this delay, the definitive Sale and Purchase Agreement, entered on or before December 29, 2025, has not been amended or terminated. Thelema has communicated the need for more time to finalize financing, keeping all other closing conditions pending. Azenta is actively assessing next steps, which introduces uncertainty for investors regarding the timing, potential renegotiation, or possible abandonment of the divestiture. This development highlights execution risks in M&A transactions dependent on buyer financing.